-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
bioAffinity Technologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2021 to Q4 2024.
- bioAffinity Technologies, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.95M, a 25.8% decline year-over-year.
- bioAffinity Technologies, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$8.95M, a 12.3% decline year-over-year.
- bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2024 was -$8.95M, a 12.3% decline from 2023.
- bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2023 was -$7.97M, a 98.8% decline from 2022.
- bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2022 was -$4.01M, a 81.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)